Report Overview
The APAC Atopic Dermatitis Treatment market size stood at around USD $2.31 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period
Atopic dermatitis(AD) is a multifaceted, chronic relapsing inflammatory skin disease that is commonly associated with otheratopicmanifestations such as food allergy, allergic rhinitis, and asthma. It is the most common skin disease in children, affecting approximately 15% to 20% of children and 1% to 3% of adults
Market Drivers
Y-O-Y growth in the incidence of atopic dermatitis in children in the Asia Pacific countries is predicted to enhance the region's market growth. The on-going efforts made by the key players for the development of novel drugs are driving market growth. Regular increases in disorders among the emerging economies are driving the growth. Growing healthcare expenses per head and upgraded health insurance coverage are stimulating the growth of the APAC region
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.